India caps trade margins on 137 cancer drugs at 30%

The National Pharmaceutical Pricing Authority has capped trade margins on 137 cancer medicines at 30%, in a notification on Saturday.
Experts found these drugs carry average mark-ups of about 170%, going up to 700% in some cases.
Prices are expected to fall between 20% and 70%, saving patients around Rs 2,500 crore a year.
Manufacturers must submit revised prices within seven days, and the new rates take effect on 9 November.

Get 100 stories a day on the app Read, watch & listen · Free on iOS & Android

Newer